Michiel van der Vlist

2.7k citations

25 papers · 2.1k indexed · 1 hit paper · h-index 13

Immunology top 2%
- Immune Cell Function and Interaction 12
- Immunotherapy and Immune Responses 10
- Immune Response and Inflammation 5
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
Virology top 2%
- HIV Research and Treatment 3
Infectious Diseases top 5%
Microbiology top 5%
Epidemiology top 10%
- Respiratory viral infections research 3
Oncology
- Cancer Immunotherapy and Biomarkers 4
Neurology
- Neuroinflammation and Neurodegeneration Mechanisms 3

Co-authors: Teunis B. H. Geijtenbeek Sonja I. Gringhuis Manja Litjens Jeroen den Dunnen Brigitte A. Wevers Tanja M. Kaptein Teun Boekhout Bart Theelen
Cited by: Immunology Virology Infectious Diseases
Journals: Nature Communications (1 paper)Neuron (1 paper)Nature reviews. Immunology (1 paper)
Partner nations: Netherlands United States Switzerland

In The Last Decade

Michiel van der Vlist

23 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Michiel van der Vlist

Since Specialization

Citations

This map shows the geographic impact of Michiel van der Vlist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiel van der Vlist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiel van der Vlist more than expected).

Fields of papers citing papers by Michiel van der Vlist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiel van der Vlist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiel van der Vlist. The network helps show where Michiel van der Vlist may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michiel van der Vlist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michiel van der Vlist Line = papers co-authored together Michiel van der Vlist links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The scavenger receptor MARCO is a ligand for the immune inhibitory receptor LAIR-1 and regulates its function in cis Science Signaling ·Akashdip Singh,Saskia V Vijver,Hajar Aglmous-Talibi,Nebojsa Jukic,Peirong Chen,Suzanne Crawley,Kalyani Mondal,Jing Zhou,Christian Niederauer,Zimple Matharu,Betty Li,Bin Fan,Michiel van der Vlist,Daniel D. Kaplan,Lee B. Rivera,James Sissons,Jonathan Sitrin,Kristina A. Ganzinger,M Inês Pascoal Ramos,Linde Meyaard	2025	0
2	Inhibitory pattern recognition receptors: lessons from LAIR1 Nature reviews. Immunology ·M Inês Pascoal Ramos,Michiel van der Vlist,Linde Meyaard	2025	3
3	A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets eLife ·Akashdip Singh,Alberto Miranda Bedate,Helen J. von Richthofen,Saskia V Vijver,Michiel van der Vlist,Raphael Kuhn,Alexander Yermanos,Jürgen Kuball,Can Keşmir,M Inês Pascoal Ramos,Linde Meyaard	2024	4
4	m6A Reader YTHDC1 Impairs Respiratory Syncytial Virus Infection by Downregulating Membrane CX3CR1 Expression Viruses ·Lucas W. Picavet,Ellen C. N. van Vroonhoven,Rianne C. Scholman,Yesper TH Smits,Rupa Banerjee,Sjanna B. Besteman,Mattheus C. Viveen,Michiel van der Vlist,Marvin E. Tanenbaum,Robert Jan Lebbink,Sebastiaan J. Vastert,Jorg van Loosdregt	2024	7
5	In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients Cancer Immunology Immunotherapy ·Laura M. Timmerman,Lobke C.M. Hensen,Mick J M van Eijs,Rik J. Verheijden,Karijn P.M. Suijkerbuijk,Linde Meyaard,Michiel van der Vlist,(unknown),(unknown),(unknown),(unknown)	2024	0
6	A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets eLife ·Akashdip Singh,Alberto Miranda Bedate,Helen J. von Richthofen,Saskia V Vijver,Michiel van der Vlist,Raphael Kuhn,Alexander Yermanos,Jürgen Kuball,Can Keşmir,M Inês Pascoal Ramos,Linde Meyaard	2024	6
7	Signaling by the inhibitory receptor CD200R is rewired by type I interferon Science Signaling ·Michiel van der Vlist,M Inês Pascoal Ramos,Lucas L. van den Hoogen,Sanne Hiddingh,Laura M. Timmerman,Titus A. P. de Hond,Ellen D. Kaan,Maarten van der Kroef,Robert Jan Lebbink,Florence Peters,William Khoury-Hanold,Ruth Fritsch‐Stork,Timothy R. D. J. Radstake,Linde Meyaard	2021	9
8	CD200R1L is a functional evolutionary conserved activating receptor in human neutrophils Journal of Leukocyte Biology ·M Inês Pascoal Ramos,Can Keşmir,Jorn E. Stok,Ruben J. Geerdink,Nikolaos Satravelas,Geertje H. A. Westerlaken,Linde Meyaard,Michiel van der Vlist	2021	6
9	Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain Neuron ·Michiel van der Vlist,Ramin Raoof,Hanneke L.D.M. Willemen,Judith Prado,Sabine Versteeg,Christian Martin Gil,Martijn Vos,Roeland E. Lokhorst,R. Jeroen Pasterkamp,Toshiyuki Kojima,Hajime Karasuyama,William Khoury-Hanold,Linde Meyaard,Niels Eijkelkamp	2021	147
10	Signal Inhibitory Receptor on Leukocytes-1 is highly expressed on lung monocytes, but absent on mononuclear phagocytes in skin and colon Cellular Immunology ·Helen J. von Richthofen,Doron Gollnast,Toni M.M. van Capel,Barbara Giovannone,Geertje H. A. Westerlaken,Lisanne Lutter,Bas Oldenburg,DirkJan Hijnen,Michiel van der Vlist,Esther C. de Jong,Linde Meyaard	2020	7
11	Differential Signalling and Kinetics of Neutrophil Extracellular Trap Release Revealed by Quantitative Live Imaging Scientific Reports ·Maarten van der Linden,Geertje H. A. Westerlaken,Michiel van der Vlist,Joris van Montfrans,Linde Meyaard	2017	79
12	Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us? Nature Reviews Rheumatology ·Michiel van der Vlist,Jürgen Kuball,Timothy R. D. J. Radstake,Linde Meyaard	2016	79
13	Human immature Langerhans cells restrict CXCR4-using HIV-1 transmission Retrovirology ·Ramin Sarrami‐Forooshani,Annelies W. Mesman,Nienke H. van Teijlingen,Joris K. Sprokholt,Michiel van der Vlist,Carla M. S. Ribeiro,Teunis B. H. Geijtenbeek	2014	32
14	Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasomebreakdown → Nature Immunology ·Sonja I. Gringhuis,Tanja M. Kaptein,Brigitte A. Wevers,Bart Theelen,Michiel van der Vlist,Teun Boekhout,Teunis B. H. Geijtenbeek	2012	471
15	Innate signaling in HIV-1 infection of dendritic cells Current Opinion in HIV and AIDS ·Michiel van der Vlist,Angelic M.G. van der Aar,Sonja I. Gringhuis,Teunis B. H. Geijtenbeek	2011	26
16	Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross‐presentation European Journal of Immunology ·Michiel van der Vlist,Lot D. de Witte,Rory D. de Vries,Manja Litjens,Marein A.W.P. de Jong,Donna Fluitsma,Rik L. de Swart,Teunis B. H. Geijtenbeek	2011	70
17	HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells Nature Immunology ·Sonja I. Gringhuis,Michiel van der Vlist,Linda Berg,Jeroen den Dunnen,Manja Litjens,Teunis B. H. Geijtenbeek	2010	211
18	Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk Nature Immunology ·Sonja I. Gringhuis,Jeroen den Dunnen,Manja Litjens,Michiel van der Vlist,Brigitte A. Wevers,Sven C. M. Bruijns,Teunis B. H. Geijtenbeek	2009	366
19	Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori Nature Immunology ·Sonja I. Gringhuis,Jeroen den Dunnen,Manja Litjens,Michiel van der Vlist,Teunis B. H. Geijtenbeek	2009	349
20	DC-SIGN and CD150 Have Distinct Roles in Transmission of Measles Virus from Dendritic Cells to T-Lymphocytes PLoS Pathogens ·Lot D. de Witte,Rory D. de Vries,Michiel van der Vlist,Selma Yüksel,Manja Litjens,Rik L. de Swart,Teunis B. H. Geijtenbeek	2008	74

About Michiel van der Vlist

Michiel van der Vlist is a scholar working on Immunology, Virology and Neurology, having authored 25 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (10 papers), Immune Response and Inflammation (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), HIV Research and Treatment (3 papers), Respiratory viral infections research (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). The work is most often cited by research in Immunology (1.3k citations), Virology (274 citations) and Infectious Diseases (375 citations). Michiel van der Vlist has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Teunis B. H. Geijtenbeek, Sonja I. Gringhuis, Manja Litjens, Jeroen den Dunnen, Brigitte A. Wevers, Tanja M. Kaptein, Teun Boekhout, Bart Theelen, Sven C. M. Bruijns and Linde Meyaard. Their work appears in journals such as Nature Communications, Neuron and Nature reviews. Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact